Le Lézard
Classified in: Health
Subjects: TDS, FVT

Flamingo Therapeutics Announces Participation in Upcoming Investor and Industry Conferences


LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today announced its participation in the following upcoming investor and industry conferences:

About Flamingo Therapeutics

Flamingo is pioneering RNA-targeted therapies for oncology with a clinical-stage pipeline targeting undruggable transcription factors and long non-coding RNAs. Flamingo has an alliance with Ionis Pharmaceuticals and is supported by well-known biotechnology investors including Andera Partners, Bpifrance Large Venture, Bpifrance through its FABS and Fonds Biothérapies Innovantes et Maladies Rares funds, Eurazeo - Kurma Partners, Perceptive Advisors, PMV, Pontifax, Sphera, Abrdn (formerly funds managed by Tekla Capital Management LLC) and VIB. 

Flamingo has initiated a Phase 2 trial 'PEMDA-HN' evaluating the STAT3 targeting agent danvatirsen, in combination with pembrolizumab, in patients with head and neck squamous cell carcinoma (HNSCC), and a Phase 1 investigator-initiated study in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS).

For more information on Flamingo, please visit:
https://flamingotx.com

PEMDA-HN on clinicaltrials.gov:
https://clinicaltrials.gov/study/NCT05814666

Danvatirsen monotherapy followed by combination with venetoclax in relapsed/ refractory AML and MDS on clincaltrials.gov:
https://classic.clinicaltrials.gov/ct2/show/NCT05986240

Please engage with us on LinkedIn:
https://www.linkedin.com/company/flamingo-therapeutics.

Flamingo Media and Investor Contact:

Amy Conrad
Juniper Point
(858) 366-3243
[email protected]

(PRNewsfoto/Flamingo Therapeutics, Inc.)

SOURCE Flamingo Therapeutics


These press releases may also interest you

at 11:45
Watercrest Senior Living Welcomes Larissa Kostal as Executive Director of Watercrest Myrtle Beach
Watercrest Senior Living Group proudly announces Larissa Kostal as Executive Director of the award-winning Watercrest Myrtle Beach Assisted Living and Memory Care community....

at 11:45
YMCA of Metropolitan Chicago Welcomes Alicia Gonzalez as Chief Sports Impact Officer
The YMCA of Metropolitan Chicago announces the appointment of Alicia Gonzalez as its Chief Sports Impact Officer. This appointment builds on the organization's rich history as a leader in sports and legacy of inspiring change through the Power of...

at 11:41
Gameto Announces New Data Demonstrating Clinical-Grade Manufacturing of In Vitro Maturation Solution for Fertility Care
Gameto, a female-led biotechnology company with a mission to redefine women's healthcare, today announced new research outlining the cellular engineering and manufacturing techniques underlying Fertilo, their novel investigational in vitro maturation...

at 11:40
Donaldson Announces Integrated Lentiviral Vector Manufacturing Platform Development
Donaldson Company, Inc. , a leading worldwide provider of innovative filtration products and solutions, announced its Isolere Bio (Isolere) and Univercells Technologies businesses are developing an integrated upstream and downstream platform for...

at 11:39
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA. The newly built 154,000-square-foot lab and...

at 11:30
HERCULES TIRES CHAMPIONS MENTAL HEALTH AWARENESS WITH STUDENT-ATHLETES IN GROUND BREAKING NIL INITIATIVE
Hercules Tires is excited to announce that throughout May, it will partner with five NCAA Division I conferences for its first-ever, conference-wide campaign to coincide with Mental Health Awareness Month. The partnership will help raise awareness...

More news about Health...


News published on and distributed by: